27 November 2024 : Clinical Research
Evaluation of Cardiometabolic Risk in Patients with Non-Functioning Adrenal Adenomas Using the Systematic Coronary Risk Evaluation 2 (SCORE2) and the Systematic Coronary Risk Evaluation 2-Older Persons (SCORE2-OP) Algorithms
Marzena Jabczyk
1ABDEF, Justyna Nowak 2ABCDE*, Sylwia Mielcarska 3CD, Bartosz Hudzik 2AC, Kinga Wołkowska-Pokrywa 3B, Elżbieta Świętochowska 3BC, Barbara Zubelewicz-Szkodzińska 14ABEFG
DOI: 10.12659/MSM.945899
Med Sci Monit 2024; 30:e945899
Table 2 Comparison of anthropometric parameters and indices between the SCORE2 and SCORE2-OP groups.
| Parameter | CVD risk based on SCORE-OP/SCORE-OP2 | P value | ||
|---|---|---|---|---|
| Low and moderate risk (N=16) | High risk (N=28) | Very high risk (N=62) | ||
| Body weight [kg] | 82.20 (68.45–95.00) | 74.4 (65.75–79.75) | 71.50 (65.20–80.70) | 0.2337 |
| Height [cm] | 165.75 (159.50–170.00) | 162.25 (157.75–169.75) | 162.00 (156.00–168.00) | 0.3764 |
| BMI index [kg/m] | 29.45 (24.75–33.35) | 28.10 (25.05–29.80) | 28.10 (25.30–30.80) | 0.64 |
| Waist circumference [cm] | 98.25 (87.50–106.50) | 95.50 (88.50–104.00) | 99.25 (89.00–108.00) | 0.5676 |
| Hip circumference [cm] | 107.50 (100.50–116.00) | 102.00 (98.00–108.00) | 103.00 (99.00–110.00) | 0.2388 |
| WHR | 0.89 (0.84–0.91) | 0.92 (0.87–0.97) | 0.95 (0.89–0.98) | b |
| BMI – body mass index; WHR – waist-to-hip ratio. b Kruskall-Wallis test: significant difference for: low risk vs moderate risk. | ||||